Bay Street News, March, 2020

– Multiple antibodies identified that neutralize SARS-CoV-2– Phase 1/2 clinical testing planned for this summerSAN FRANCISCO, March 25, 2020 (GLOBE […]

DUBLIN, Ireland, March 25, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, […]

Continues to materially exceed operational output requirementsHighly efficient and affordable electrical output and heat productionIdeal solution for the South Korea […]

HOLLYWOOD, Fla., March 25, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]

Phase 4 Head-to-Head Study in Patients with Stage 3 or 4 Chronic Kidney Disease Phase 2 Trial in Patients with Stage […]

ATLANTA, March 25, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or “Company”), a leader in the commercialization […]

MORRIS PLAINS, N.J., March 25, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]

MELBOURNE, Australia, March 25, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s […]

TORONTO, March 25, 2020 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQB: “LONCF”) announces that […]

TORONTO, March 25, 2020 (GLOBE NEWSWIRE) —Reported assets under management of $37.4 billionPrivate Alternatives AUM increased 5.3% in the quarter […]